Pages that link to "Q56698026"
Jump to navigation
Jump to search
The following pages link to Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720 (Q56698026):
Displaying 50 items.
- Immunomodulatory drug FTY720 induces regulatory CD4( )CD25( ) T cells in vitro (Q24648847) (← links)
- FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis (Q28288357) (← links)
- Antibody against a novel, myriocin (ISP-I)-based immunosuppressant, FTY720 (Q28373033) (← links)
- Drug discovery prospect from untapped species: indications from approved natural product drugs (Q28481257) (← links)
- Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons (Q28486184) (← links)
- Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis (Q30458371) (← links)
- Ubiquitin Pathway Proteins Influence the Mechanism of Action of the Novel Immunosuppressive Drug FTY720 in Saccharomyces cerevisiae (Q31140135) (← links)
- Recent advances in immunosuppressants. (Q33681499) (← links)
- FTY720: mechanisms of action and its effect on organ transplantation (review). (Q33782588) (← links)
- Role of natural product diversity in chemical biology (Q33871943) (← links)
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis (Q34624835) (← links)
- Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720. (Q34756546) (← links)
- Fingolimod (FTY720) stimulates Ca(2 )/calcineurin signaling in fission yeast (Q35061388) (← links)
- FTY720: A new kid on the block for transplant immunosuppression (Q35164822) (← links)
- FTY720: from bench to bedside (Q35711510) (← links)
- Insights into the pharmacological relevance of lysophospholipid receptors (Q35853199) (← links)
- Lysophospholipids as mediators of immunity (Q36472040) (← links)
- Fingolimod: a novel immunosuppressant for multiple sclerosis (Q36929186) (← links)
- Finding a way out: lymphocyte egress from lymphoid organs (Q37008187) (← links)
- Sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis (Q37148742) (← links)
- FTY720 (fingolimod) for relapsing multiple sclerosis. (Q37154788) (← links)
- Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects (Q37228601) (← links)
- Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8) (Q37729461) (← links)
- Development of small-molecule therapies for autoimmune diseases (Q37730104) (← links)
- Roles for lysophospholipid S1P receptors in multiple sclerosis (Q37803419) (← links)
- Natural product drug discovery: the successful optimization of ISP-1 and halichondrin B (Q37891570) (← links)
- Sphingosine 1-phosphate in coagulation and inflammation. (Q37909176) (← links)
- Discovery Of Fingolimod, The Sphingosine 1-Phosphate Receptor Modulator And Its Application For The Therapy Of Multiple Sclerosis (Q38005193) (← links)
- FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation. (Q38723000) (← links)
- Fingolimod provides long-term protection in rodent models of cerebral ischemia (Q38806688) (← links)
- New Immunosuppressive Sphingoid Base and Ceramide Analogues in Wild Cordyceps (Q39102550) (← links)
- The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration. (Q39345870) (← links)
- Oral pharmacokinetic and pharmacodynamic effects of FTY720 in cats (Q40252568) (← links)
- Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology (Q40346135) (← links)
- Elimination of Cell-cycle Regulators during Caspase-3-dependent Apoptosis Caused by an Immunosuppressant, FTY720 (Q40651245) (← links)
- Effect of a New Immunosuppressive Agent, Fty720, on Survival of Islet Allografts (Q40845989) (← links)
- Effect of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice (Q41769122) (← links)
- A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis (Q41852835) (← links)
- FTY720 attenuates accumulation of EMAP-II and MHC-II monocytes in early lesions of rat traumatic brain injury (Q42076881) (← links)
- Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides (Q42443655) (← links)
- Impurities of crude glycerol and their effect on metabolite production (Q42764669) (← links)
- Effects of different dose of FTY720 on lymphocyte cell cycle arrest in cardiac transplantation model of rats (Q43143169) (← links)
- Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis (Q43602420) (← links)
- FTY-720 is efficacious in monkey kidney transplantation (Q43620849) (← links)
- Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy. (Q44008865) (← links)
- A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine (Q44100057) (← links)
- Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts (Q44101226) (← links)
- FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration (Q44188438) (← links)
- Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. (Q44482860) (← links)
- Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis (Q45004851) (← links)